Nathan Rich
Stock Analyst at Goldman Sachs
(1.33)
# 3,328
Out of 4,711 analysts
89
Total ratings
36.51%
Success rate
-11.45%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $14.09 | +49.04% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $164.84 | +18.90% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $18.70 | +60.43% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $7.78 | +2.83% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $18.70 | -6.42% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $247.10 | +55.81% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $11.63 | +20.38% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Neutral | $10 → $11 | $22.09 | -50.20% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $211.06 | +6.60% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $412.26 | +57.67% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $30 | $30.86 | -2.79% | 5 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $44.36 | +98.38% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $10.61 | +13.10% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $69.82 | +21.74% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $12.52 | -12.14% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $294.73 | +13.66% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $500.13 | +6.97% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $14.09
Upside: +49.04%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $164.84
Upside: +18.90%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $18.70
Upside: +60.43%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $7.78
Upside: +2.83%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $18.70
Upside: -6.42%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $247.10
Upside: +55.81%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $11.63
Upside: +20.38%
Teva Pharmaceutical
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $22.09
Upside: -50.20%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $211.06
Upside: +6.60%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $412.26
Upside: +57.67%
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $30.86
Upside: -2.79%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $44.36
Upside: +98.38%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $10.61
Upside: +13.10%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $69.82
Upside: +21.74%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $12.52
Upside: -12.14%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $294.73
Upside: +13.66%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $500.13
Upside: +6.97%